Making small changes in diet, meal timing, and hydration can help reduce symptoms
GLP-2 has stayed in a small therapeutic niche
Extracellular glutathione suppresses human lung fibroblast proliferation
Your GP or diabetes specialist should: Evaluate whether symptoms coincide with dose escalation (suggesting a possible connection to treatment) Review all concurrent medications for potential contributors Assess for alternative causes, particularly thyroid function and menopausal status in women Consider whether glycaemic control has changed significantly Review insulin or sulfonylurea doses if hypoglycaemia is suspected For women experiencing menopausal hot flushes, hormone replacement therapy (HRT) is generally considered first-line treatment where appropriate, in line with NICE guidance
Suppression of NFS1 alone does not induce ferroptosis, but when cells produce large amounts of ROS, iron starvation induced by inhibition of NFS1 promotes ferroptosis
This limitation has made GLP-1 receptor agonists an increasingly popular option for more effective weight management